nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A DS-1 like G9P[6] human strain CDC-6 as a new rotavirus vaccine candidate
|
Wang, Yuhuan |
|
2018 |
36 |
45 |
p. 6844-6849 |
artikel |
2 |
Antigenic and sequence variability of the human respiratory syncytial virus F glycoprotein compared to related viruses in a comprehensive dataset
|
Mas, Vicente |
|
2018 |
36 |
45 |
p. 6660-6673 |
artikel |
3 |
Assessing the effectiveness of high-dose influenza vaccine in preventing hospitalization among seniors, and observations on the limitations of effectiveness study design
|
Robison, Steve G. |
|
2018 |
36 |
45 |
p. 6683-6687 |
artikel |
4 |
Challenges to sustainable immunization systems in Gavi transitioning countries
|
Cernuschi, Tania |
|
2018 |
36 |
45 |
p. 6858-6866 |
artikel |
5 |
Co-delivery of amphipol-conjugated adjuvant with antigen, and adjuvant combinations, enhance immune protection elicited by a membrane protein-based vaccine against a mucosal challenge with Chlamydia
|
Tifrea, Delia F. |
|
2018 |
36 |
45 |
p. 6640-6649 |
artikel |
6 |
Communication-based interventions for increasing influenza vaccination rates among Aboriginal children: A randomised controlled trial
|
Borg, Kim |
|
2018 |
36 |
45 |
p. 6790-6795 |
artikel |
7 |
Comprehensive analysis of antibody responses to Plasmodium falciparum erythrocyte membrane protein 1 domains
|
Kanoi, Bernard N. |
|
2018 |
36 |
45 |
p. 6826-6833 |
artikel |
8 |
Concomitant HPV and MenACWY vaccination among sixth and seventh graders receiving Tdap
|
Doke, Kaleigh |
|
2018 |
36 |
45 |
p. 6819-6825 |
artikel |
9 |
Corrigendum to “Designing an immunocyte-targeting delivery system by use of beta-glucan” [Vaccine 36 (2018) 186–189]
|
Miyamoto, Noriko |
|
2018 |
36 |
45 |
p. 6892 |
artikel |
10 |
Corrigendum to “One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life” [Vaccine 36 (2018) 381–387]
|
Henry, Ouzama |
|
2018 |
36 |
45 |
p. 6894 |
artikel |
11 |
Corrigendum to “Simulation studies to assess the long-term effects of Japan’s change from trivalent to quadrivalent influenza vaccination” [Vaccine 36 (2018) 624–630]
|
Tsuzuki, Shinya |
|
2018 |
36 |
45 |
p. 6893 |
artikel |
12 |
Cost and burden of RSV related hospitalisation from 2012 to 2017 in the first year of life in Lyon, France
|
Kramer, Rolf |
|
2018 |
36 |
45 |
p. 6591-6593 |
artikel |
13 |
Cost of herpes zoster and herpes zoster-related complications among immunocompromised individuals
|
Meyers, Juliana L. |
|
2018 |
36 |
45 |
p. 6810-6818 |
artikel |
14 |
Cryptosporidium spp. CP15 and CSL protein-derived synthetic peptides’ immunogenicity and in vitro seroneutralisation capability
|
Avendaño, Catalina |
|
2018 |
36 |
45 |
p. 6703-6710 |
artikel |
15 |
CYTED Network to develop an immunogen compatible with integrated management strategies for tick control in cattle
|
Rodríguez-Mallon, Alina |
|
2018 |
36 |
45 |
p. 6581-6586 |
artikel |
16 |
Editorial Board/Aims and Scope
|
|
|
2018 |
36 |
45 |
p. IFC |
artikel |
17 |
Epitope clustering analysis for vaccine-induced human antibodies in relationship to a panel of murine monoclonal antibodies against HPV16 viral capsid
|
Zhang, Cai |
|
2018 |
36 |
45 |
p. 6761-6771 |
artikel |
18 |
Evaluation of a conjugate vaccine platform against enterotoxigenic Escherichia coli (ETEC), Campylobacter jejuni and Shigella
|
Laird, Renee M. |
|
2018 |
36 |
45 |
p. 6695-6702 |
artikel |
19 |
Expenditures on vaccine-preventable disease surveillance: Analysis and evaluation of comprehensive multi-year plans (cMYPs) for immunization
|
Hossain, Azfar |
|
2018 |
36 |
45 |
p. 6850-6857 |
artikel |
20 |
Golden-star nanoparticles as adjuvant effectively promotes immune response to foot-and-mouth disease virus-like particles vaccine
|
Teng, Zhidong |
|
2018 |
36 |
45 |
p. 6752-6760 |
artikel |
21 |
Impact of early life exposure to ionizing radiation on influenza vaccine response in an elderly Japanese cohort
|
Hayashi, Tomonori |
|
2018 |
36 |
45 |
p. 6650-6659 |
artikel |
22 |
Increasing trend in invasive non-typeable Haemophilus influenzae disease and molecular characterization of the isolates, Italy, 2012–2016
|
Giufrè, Maria |
|
2018 |
36 |
45 |
p. 6615-6622 |
artikel |
23 |
Inequalities in childhood vaccination timing and completion in London
|
Tiley, Karen S. |
|
2018 |
36 |
45 |
p. 6726-6735 |
artikel |
24 |
Investigation of an increase in large local reactions following vaccine schedule change to include DTaP-HB-IPV-Hib (Infanrix-hexa®) and MMRV (ProQuad®) at 18 months of age
|
Kiely, Marilou |
|
2018 |
36 |
45 |
p. 6688-6694 |
artikel |
25 |
Longevity of adenovirus vector immunity in mice and its implications for vaccine efficacy
|
Sayedahmed, Ekramy E. |
|
2018 |
36 |
45 |
p. 6744-6751 |
artikel |
26 |
Mitigating bias in observational vaccine effectiveness studies using simulated comparator populations: Application to rotavirus vaccination in the UK
|
Hungerford, Daniel |
|
2018 |
36 |
45 |
p. 6674-6682 |
artikel |
27 |
No evidence found for an increased risk of long-term fatigue following human papillomavirus vaccination of adolescent girls
|
Schurink-van't Klooster, T.M. |
|
2018 |
36 |
45 |
p. 6796-6802 |
artikel |
28 |
Non-clinical safety assessment of repeated intramuscular administration of an EV-A71 VLP vaccine in rabbits
|
Salmons, Brian |
|
2018 |
36 |
45 |
p. 6623-6630 |
artikel |
29 |
Obituary
|
Tine, John A. |
|
2018 |
36 |
45 |
p. 6579-6580 |
artikel |
30 |
Oral administration of coated PEDV-loaded microspheres elicited PEDV-specific immunity in weaned piglets
|
Wen, Zhifen |
|
2018 |
36 |
45 |
p. 6803-6809 |
artikel |
31 |
Potent effect of KISS1-54 DNA vaccine compared with KISS1-10 DNA vaccine in inhibiting the fertility of female rats
|
Han, Yanguo |
|
2018 |
36 |
45 |
p. 6631-6639 |
artikel |
32 |
Pregnant women’s attitudes toward Zika virus vaccine trial participation
|
Goldfarb, Ilona Telefus |
|
2018 |
36 |
45 |
p. 6711-6717 |
artikel |
33 |
Reply to Lee et al.’s letter to the editor pertaining to our publication entitled “Pain caused by measles, mumps, and rubella vaccines: A systematic literature review”
|
Willame, Corinne |
|
2018 |
36 |
45 |
p. 6589-6590 |
artikel |
34 |
Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: A phase II, randomized, dose-finding trial
|
Chu, Kai |
|
2018 |
36 |
45 |
p. 6782-6789 |
artikel |
35 |
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naïve adults ≥50 years of age
|
Ermlich, Susan J. |
|
2018 |
36 |
45 |
p. 6875-6882 |
artikel |
36 |
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants
|
Greenberg, David |
|
2018 |
36 |
45 |
p. 6883-6891 |
artikel |
37 |
Tetanus-diphtheria vaccination in adults: the long-term persistence of antibodies is not dependent on polyclonal B-cell activation and the defective response to diphtheria toxoid re-vaccination is associated to HLADRB1∗01
|
Ferlito, Claudia |
|
2018 |
36 |
45 |
p. 6718-6725 |
artikel |
38 |
The bivalent factor H binding protein meningococcal serogroup B vaccine elicits bactericidal antibodies against representative non-serogroup B meningococci
|
Harris, Shannon L. |
|
2018 |
36 |
45 |
p. 6867-6874 |
artikel |
39 |
The diversity of the proline-rich domain of pneumococcal surface protein A (PspA): Potential relevance to a broad-spectrum vaccine
|
Mukerji, Reshmi |
|
2018 |
36 |
45 |
p. 6834-6843 |
artikel |
40 |
The Euvichol story – Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships
|
Odevall, Lina |
|
2018 |
36 |
45 |
p. 6606-6614 |
artikel |
41 |
Therapeutic human papillomavirus vaccines in head and neck cancer: A systematic review of current clinical trials
|
Schneider, Katrine |
|
2018 |
36 |
45 |
p. 6594-6605 |
artikel |
42 |
To the editor: Response to Willame, et al., published in Vaccine 35 (2017) 5551–5558, entitled “Pain caused by measles, mumps, and rubella vaccines: A systematic literature review”
|
Lee, Andrew W. |
|
2018 |
36 |
45 |
p. 6587-6588 |
artikel |
43 |
U.S. clinicians’ and pharmacists’ reported barriers to implementation of the Standards for Adult Immunization Practice
|
Srivastav, Anup |
|
2018 |
36 |
45 |
p. 6772-6781 |
artikel |
44 |
Vaccine safety surveillance in pregnancy in low- and middle-income countries using GAIA case definitions: A feasibility assessment
|
Stuurman, Anke L. |
|
2018 |
36 |
45 |
p. 6736-6743 |
artikel |